Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,...
Patent
1995-03-13
2000-10-24
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
4241341, 4241791, 424809, 5303871, 5303873, 5303911, 5303919, A61K 39395, C07K 1600, C07K 1700
Patent
active
061363138
ABSTRACT:
This invention is directed to intermediates for use in the preparation of chimeric antibodies and synthetic antibody derivatives. The intermediates are open- or closed-hinge Fc fragments that have at least one alkylated external sulphydryl group. The invention is also directed to processes for making such intermediates, chimeric antibodies or synthetic antibody derivatives produced from the intermediates, and to methods of treating B-cell Lymphoma by administering chimeric antibodies or synthetic antibody derivatives produced using the intermediates of the invention.
REFERENCES:
patent: 4719107 (1988-01-01), Carosella
Stevenson, G.T., et al., Chemical Abstracts, vol. 110, No. 23, Abstract No. 110:210562a, pp. 552-553, (1989).
Stevenson, et al., Molecular and Cellular Biochemistry, vol. 91:33-38, (1989).
Stevenson, et al., Anti-Cancer Drug Design, vol. 3:219-230; (1989).
Waldmann, T.A., et al., Science, vol. 252, pp. 1657-1662 (1991).
Hawkins, Robert E., et al., BMJ, vol. 305, pp. 1348-1352, (1992).
Rudinger, J., Peptide Hormones, Parsons (edited), University Park Press, pp. 1-7 (1976).
Stevenson et al. (1985a) Cancer Surveys 4(1):213-244.
Watts et al., (1985) Mol. Immunol. 22(7):803-810.
Achutamurthy Ponnathapura
Imperial College Innovations Limited
LandOfFree
Processes and intermediates for synthetic antibody derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Processes and intermediates for synthetic antibody derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Processes and intermediates for synthetic antibody derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960613